UCSF

ZINC03871541

Substance Information

In ZINC since Heavy atoms Benign functionality
October 4th, 2005 16 Yes

Other Names:

grel-

6,7-Dichlor-1,5-dihydroimidazo(2,1-b)chinazolin-2(3H)-on

6,7-Dichloro-1,5-dihydroimidazo(2,1-b)-quinazolin-2(3H)-one monohydrochloride; 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one hydrochloride; AGRYLIN; ANAGRELIDE HYDROCHLORIDE; Agrelin; Anagrelid hydrochlorid; Anagrelide Hydrocholoride; Anagrel

6,7-Dichloro-1,5-dihydroimidazo(2,1-b)-quinazolin-2(3H)-one monohydrochloride; Anagrelid hydrochlorid; Anagrelide HCL

6,7-Dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one

6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one

6,7-dichloro-1,5-dihydroimidazo[2,1-]quinazolin-2(3H)-one

6,7-dichloro-1H,2H,3H,5H-imidazolidino[2,1-b]quinazolin-2-one hydrochloride

6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one

6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one

6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride

68475-42-3

68475-42-3; Anagrelide (INN/BAN); D07455

823178-43-4; Anagrelide hydrochloride hydrate (JAN); Anagrelide hydrochloride monohydrate; D10255

AC-3401

AC1L1D3U

Agrelin

Agrylin

Anagrelida

Anagrelida [INN-Spanish]

anagrelida; anagrelide; anagrelidum

Anagrelide

Anagrelide (BAN

Anagrelide (INN/BAN)

Anagrelide HCl

Anagrelide HCl monohydrate

ANAGRELIDE HCl; CPD000469168; SAM001246604

Anagrelide [BAN:INN]

Anagrelide [INN:BAN]

anagrelidehydrochloride

Anagrelidum

Anagrelidum [INN-Latin]

BIDD:GT0711

BL 416201

BL-4162a

BMY-26538-01

BRN 0619582

C10H7Cl2N3O

CHEBI:142290

CHEMBL760

CID2182

CPD000469168; ANAGRELIDE HCl

CPD000469168; SAM001246604; anagrelide hydrochloride

D07455

DAP000612

HMS2089D21

HSDB 7325

I14-11970

Imidazo(2,1-b)quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-

INN); Anagrelide HCl (FDA

INN); Anagrelide Hydrochloride (FDA

KRN-654

LS-80464

MFCD00866794

MFCD01720337

MFCD09839188

MolPort-003-844-624

MolPort-005-934-314

N/A

NCGC00161408-01

QA-0023

SPD-422

Thromboreductin

UNII-K9X45X0051

USAN)

Xagrid

ZINC03871541

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.77 5.23 -11.96 1 4 0 45 256.092 0

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 2.79e-01 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Therapy antithrombotic SMDC Pharmakon
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP05646a; 1 hydrogen chloride NIH Clinical Collection via PubChem
Target PDE Selleck Chemicals
Indications primary thrombocythemia KeyOrganics Bioactives
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP05646a; SALT: 1 hydrogen chloride NIH Clinical Collection via PubChem
Purity ¡Ý98.5£¥ APIChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
PDE3A-1-E Phosphodiesterase 3A (cluster #1 Of 2), Eukaryotic Eukaryotes 82 0.62 Binding ≤ 10μM
PDE3B-1-E Phosphodiesterase 3B (cluster #1 Of 2), Eukaryotic Eukaryotes 82 0.62 Binding ≤ 10μM
P2Y12-1-E Purinergic Receptor P2Y12 (cluster #1 Of 2), Eukaryotic Eukaryotes 1050 0.52 Functional ≤ 10μM
PDE3A-1-E Phosphodiesterase 3A (cluster #1 Of 1), Eukaryotic Eukaryotes 50 0.64 Functional ≤ 10μM
PDE3B-1-E Phosphodiesterase 3B (cluster #1 Of 1), Eukaryotic Eukaryotes 50 0.64 Functional ≤ 10μM
Z50587-1-O Homo Sapiens (cluster #1 Of 9), Other Other 2600 0.49 Functional ≤ 10μM
Z50592-3-O Oryctolagus Cuniculus (cluster #3 Of 8), Other Other 270 0.57 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 800 0.53 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
PDE3A_HUMAN Q14432 Phosphodiesterase 3A, Human 54 0.64 Binding ≤ 1μM
PDE3B_HUMAN Q13370 Phosphodiesterase 3B, Human 54 0.64 Binding ≤ 1μM
PDE3A_HUMAN Q14432 Phosphodiesterase 3A, Human 1050 0.52 Binding ≤ 10μM
PDE3B_HUMAN Q13370 Phosphodiesterase 3B, Human 1050 0.52 Binding ≤ 10μM
Z50587 Z50587 Homo Sapiens 1050 0.52 Functional ≤ 10μM
Z50592 Z50592 Oryctolagus Cuniculus 1050 0.52 Functional ≤ 10μM
PDE3A_HUMAN Q14432 Phosphodiesterase 3A, Human 50 0.64 Functional ≤ 10μM
PDE3B_HUMAN Q13370 Phosphodiesterase 3B, Human 50 0.64 Functional ≤ 10μM
P2Y12_HUMAN Q9H244 Purinergic Receptor P2Y12, Human 1050 0.52 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 20 0.67 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
ADP signalling through P2Y purinoceptor 12
cGMP effects
G alpha (i) signalling events
G alpha (s) signalling events
P2Y receptors
PDE3B signalling

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.